Epam Systems (EPAM) Drops 11.47% on February 05

Equities Staff |

Epam Systems (EPAM) was one of the Russell 2000's biggest losers for Friday February 05 as the stock slid 11.47% to $60.96, a loss of $-7.899 per share. Starting at an opening price of $68.26 a share, the stock traded between $58.67 and $68.26 over the course of the trading day. Volume was 1.64 million shares over 12,924 trades, against an average daily volume of 429,471 shares and a total float of 49.97 million.

The losses send Epam Systems down to a market cap of $3.05 billion. In the last year, Epam Systems has traded between $84.41 and $50.31, and its 50-day SMA is currently $76.15 and 200-day SMA is $73.24.

The stock has a P/E Ratio of 48.3.

EPAM Systems Inc is a provider of software engineering solutions and information technology services to clients in different locations. Its services include product development, application development, application testing, & among others.

Epam Systems is based out of Newtown, PA and has some 14,109 employees. Its CEO is Arkadiy Dobkin.

For a complete fundamental analysis analysis of Epam Systems, check out Equities.com’s Stock Valuation Analysis report for EPAM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.